BeStock  
Stocks › Biotechnology › TNGX

Tango Therapeutics TNGX

US equityMarket cap rank #2271Biotechnology
$21.73 −$0.98 (-4.32%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $22.00 +1.24%
Open$22.11
Prev close$22.71
Day range$21.63 – $23.05
Volume1.74M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-18.5x
CheapRich

Near the bottom of its 5-year range · 14th percentile, 5-year average -8.7x

Price / book4.4x
CheapRich

Above its usual level · 76th percentile, 5-year average 3.8x

#4254 of 5330 stocks by PB (1 = cheapest)

Price / sales80.3x
CheapRich

Near the top of its 5-year range · 98th percentile, 5-year average 24.7x

#4920 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-39x-25x-11x3xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$22.92
Price vs. fair value-5.2%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.41 – 3.75 76% (pricier than usual) #4254 of 5330 (1 = cheapest)
PE -18.48 -13.85 -8.75 14% (cheaper than usual) –
PS 80.30 1,276.28 24.66 98% (pricier than usual) #4920 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TNGX.

Sign in to join the discussion.

Scroll to Top